What kind of physical monitoring do you usually do for adults on ADHD meds?

Adults taking medication for ADHD do not require a rigid or mandatory long-term monitoring protocol, but good clinical practice supports regular physical health review to ensure safety, tolerability, and ongoing benefit. Monitoring is proportionate to the medication used, the individual’s medical risk factors, and clinical response. Before starting treatment, baseline measures typically include blood pressure, heart rate, weight, and a brief cardiovascular history, including personal or family history of cardiac disease. An ECG is not routinely required in healthy adults but may be appropriate if there are cardiac symptoms, significant risk factors, or concerning findings. Once treatment is established, blood pressure and pulse are usually monitored periodically, particularly during titration and dose changes, as stimulants and some non-stimulants can cause modest increases in heart rate or blood pressure. Weight and appetite should also be reviewed, especially if there are concerns about weight loss, reduced intake, or gastrointestinal side effects. Follow-up appointments also focus on physical symptoms that may develop over time, such as sleep disturbance, headaches, palpitations, sweating, or jitteriness. For people with conditions like hypertension, anxiety disorders, or higher cardiovascular risk, closer or more frequent monitoring may be appropriate. Routine blood tests are not required solely due to ADHD medication use unless clinically indicated. Importantly, physical monitoring should be integrated with functional review—assessing whether the medication continues to meaningfully improve attention, daily functioning, and quality of life.

Before starting stimulants or atomoxetine, I usually establish a baseline. That includes blood pressure, heart rate, weight, and a cardiovascular history. I’m asking about things like known heart disease, fainting, palpitations, chest pain, or a strong family history of sudden cardiac events. In adults without cardiac risk factors or symptoms, a routine ECG is not generally required, but it may be ordered if there are red flags or uncertainty. After starting medication, the main things I monitor are blood pressure and heart rate. Both stimulants and atomoxetine can cause small average increases, so I typically recheck these after dose changes and during early follow-up. In real life, that’s often every few weeks during titration, then every 6 to 12 months once the dose is stable and readings are normal. Weight is also monitored, especially in the first year. Appetite suppression can lead to unintentional weight loss for some adults, so trends matter more than a single measurement. I also routinely ask about sleep, anxiety, exercise tolerance, and whether the medication feels physically comfortable, even though those aren’t formal “vitals.” ECGs are usually symptom-driven rather than routine. New chest pain, significant palpitations, fainting, shortness of breath, or sustained high blood pressure would prompt further cardiac evaluation. For atomoxetine specifically, I still monitor blood pressure and heart rate, and I ask about liver-related symptoms, although serious liver issues are rare. Overall, for most healthy adults, ADHD medications are well tolerated long term with simple, regular monitoring. Good monitoring isn’t excessive testing. It’s consistent check-ins, awareness of symptoms, and adjusting if the body gives us new information.